Suzuken Co (9987) Price & Analysis

Compare

0 Followers

9987 Stock Chart & Stats

¥6337.00

-¥26.00(-0.55%)

At close: Jan 08 4:00 PM EST

¥6337.00

-¥26.00(-0.55%)

Day’s Range― - ―

52-Week Range¥4,406.00 - ¥6,668.00

Previous CloseN/A

Volume197.40K

Average Volume (3M)163.97K

Market Cap

¥354.21B

Enterprise Value¥315.53B

Total Cash (Recent Filing)¥142.20B

Total Debt (Recent Filing)¥23.85B

Price to Earnings (P/E)12.7

Beta0.40

Next Earnings

May 18, 2026

EPS Estimate

97.55

Next Dividend Ex-DateN/A

Dividend Yield1.6%

Share Statistics

EPS (TTM)211.65

Shares Outstanding72,167,206

10 Day Avg. Volume143,650

30 Day Avg. Volume163,966

Financial Highlights & Ratios

PEG Ratio0.40

Price to Book (P/B)0.92

Price to Sales (P/S)0.16

P/FCF Ratio-4.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Balance Sheet StrengthExtremely low leverage and a healthy equity ratio give Suzuken durable financial flexibility. Minimal debt reduces refinancing risk and interest burden, enabling the company to fund working capital, support suppliers, and absorb shocks while navigating revenue headwinds over the next months.

Margin Stability & EfficiencyConsistent gross margins and modest improvements in EBIT/EBITDA margins point to effective cost control and operational efficiency. These margin dynamics help preserve profitability and operational cash generation even if top-line recovery is gradual, supporting medium-term sustainability.

Market Position & Distribution NetworkA large, entrenched distribution network and close provider relationships create a durable competitive advantage. High distribution coverage and trust with hospitals, clinics and pharmacies supports stable recurring demand, supplier access, and cross-selling of logistics and IT services over time.

Bears Say

Sharp Revenue DeclineA 45% drop in revenue is a structural concern that undermines scale advantages and fixed-cost absorption. Sustained top-line contraction can weaken bargaining power with suppliers, force margin trade-offs, and erode cash generation, increasing execution risk across the business in coming quarters.

Negative Operating & Free Cash FlowNegative operating and free cash flow indicate liquidity stress despite positive net income metrics. Persistent cash outflows constrain the company’s ability to fund inventory and logistics cycles in distribution, may require external funding, and raises short-to-medium term solvency and execution concerns.

Thin Net Profit MarginA net margin near 1.4% provides limited downside protection against cost inflation or further revenue loss. Low margin compresses retained earnings and reinvestment capacity, reduces buffer for capital expenditures or strategic initiatives, and heightens sensitivity to operational disruptions.

Suzuken Co News

Suzuken Reshapes Pharmaceutical Logistics with Intra-Group Split and New Subsidiary

Suzuken Co ( ($JP:9987) ) has provided an announcement. Suzuken will restructure its intra-group logistics operations by carving...

4d ago

Suzuken posts higher sales but weaker profits and lower equity ratio for nine months

Suzuken Co ( ($JP:9987) ) has issued an announcement. Suzuken reported consolidated net sales of ¥1.89 trillion for...

4d ago

Suzuken Updates Progress on Ongoing Share Repurchase Program

An announcement from Suzuken Co ( ($JP:9987) ) is now available. Suzuken Co., Ltd. reported the January 2026...

15d ago

Suzuken Advances Toward Completion of ¥26 Billion Share Buyback Program

The latest update is out from Suzuken Co ( ($JP:9987) ). Suzuken Co., Ltd. reported that it repurchased...

1M ago

Suzuken Co. Updates on November 2025 Share Repurchase

Suzuken Co ( ($JP:9987) ) has shared an update. Suzuken Co., Ltd. announced the results of its share...

3M ago

Suzuken Co. Completes Share Repurchase to Enhance Capital Flexibility

Suzuken Co ( ($JP:9987) ) has issued an announcement. Suzuken Co., Ltd. announced the completion of a share...

3M ago

Suzuken Co. Updates on Share Repurchase Progress

An update from Suzuken Co ( ($JP:9987) ) is now available. Suzuken Co., Ltd. announced the results of...

3M ago

Suzuken Co. Announces Share Repurchase Plan

Suzuken Co ( ($JP:9987) ) has shared an announcement. Suzuken Co., Ltd. has announced a share repurchase plan,...

3M ago

Suzuken Co. Reports Higher-than-Expected Profits Despite Sales Shortfall

Suzuken Co ( ($JP:9987) ) has shared an announcement. Suzuken Co., Ltd. reported variances between its forecasted and...

3M ago

Suzuken Co. Reports Mixed Financial Results for First Half of 2025

Suzuken Co ( ($JP:9987) ) has shared an announcement. Suzuken Co., Ltd. reported its consolidated financial results for...

3M ago

Suzuken upgraded to Buy from Hold at Jefferies

Jefferies upgraded Suzuken to Buy from Hold with a price target of 5,900 yen, up from 5,200 yen....

2y ago

Suzuken downgraded to Neutral from Buy at Citi

Citi downgraded Suzuken to Neutral from Buy with a price target of 5,200 yen, up from 4,800 yen....

2y ago

SZUKF

9987 FAQ

What was Suzuken Co Ltd’s price range in the past 12 months?

Suzuken Co Ltd lowest stock price was ¥4406.00 and its highest was ¥6668.00 in the past 12 months.

What is Suzuken Co Ltd’s market cap?

Suzuken Co Ltd’s market cap is ¥354.21B.

When is Suzuken Co Ltd’s upcoming earnings report date?

Suzuken Co Ltd’s upcoming earnings report date is May 18, 2026 which is in 91 days.

How were Suzuken Co Ltd’s earnings last quarter?

Suzuken Co Ltd released its earnings results on Feb 12, 2026. The company reported ¥211.65 earnings per share for the quarter, beating the consensus estimate of ¥97.202 by ¥114.448.

Is Suzuken Co Ltd overvalued?

According to Wall Street analysts Suzuken Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Suzuken Co Ltd pay dividends?

Suzuken Co Ltd pays a Semiannually dividend of ¥50 which represents an annual dividend yield of 1.6%. See more information on Suzuken Co Ltd dividends here

What is Suzuken Co Ltd’s EPS estimate?

Suzuken Co Ltd’s EPS estimate is 97.55.

How many shares outstanding does Suzuken Co Ltd have?

Suzuken Co Ltd has 72,167,206 shares outstanding.

What happened to Suzuken Co Ltd’s price movement after its last earnings report?

Suzuken Co Ltd reported an EPS of ¥211.65 in its last earnings report, beating expectations of ¥97.202. Following the earnings report the stock price went down -3.638%.

Which hedge fund is a major shareholder of Suzuken Co Ltd?

Currently, no hedge funds are holding shares in JP:9987

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Suzuken Co Ltd

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.